Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 16
2020 16
2021 9
2022 8
2023 12
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review.
Martina E, Diotallevi F, Radi G, Campanati A, Offidani A. Martina E, et al. Toxins (Basel). 2021 Feb 5;13(2):120. doi: 10.3390/toxins13020120. Toxins (Basel). 2021. PMID: 33562846 Free PMC article.
The best-reported evidence concerns focal idiopathic hyperhidrosis, Raynaud phenomenon, suppurative hidradenitis, Hailey-Hailey disease, epidermolysis bullosa simplex Weber-Cockayne type, Darier's disease, pachyonychia congenita, aquagenic keratoderma, alopecia, pso …
The best-reported evidence concerns focal idiopathic hyperhidrosis, Raynaud phenomenon, suppurative hidradenitis, Hailey-Hailey disease, epi …
Pediatric Nail Disorders.
Bellet JS. Bellet JS. Dermatol Clin. 2021 Apr;39(2):231-243. doi: 10.1016/j.det.2020.12.005. Epub 2021 Feb 10. Dermatol Clin. 2021. PMID: 33745636 Review.
Pachyonychia Congenita.
Tan Y, Ma DL. Tan Y, et al. Indian J Pediatr. 2024 Mar;91(3):300-301. doi: 10.1007/s12098-023-04567-z. Epub 2023 Jun 8. Indian J Pediatr. 2024. PMID: 37289311 No abstract available.
Coexistence of pachyonychia congenita and hidradenitis suppurativa: more than a coincidence.
Pavlovsky M, Peled A, Sarig O, Astman N, Malki L, Meijers O, Assaf S, Schwartz J, Malovitski K, Hansen D, Sprecher E, Samuelov L. Pavlovsky M, et al. Br J Dermatol. 2022 Sep;187(3):392-400. doi: 10.1111/bjd.21674. Epub 2022 Jun 17. Br J Dermatol. 2022. PMID: 35606927 Free PMC article.
BACKGROUND: The coexistence of pachyonychia congenita (PC) and hidradenitis suppurativa (HS) has been described in case reports. ...What is already known about this topic? The coexistence of pachyonychia congenita (PC) and hidradenitis suppurativa (HS) …
BACKGROUND: The coexistence of pachyonychia congenita (PC) and hidradenitis suppurativa (HS) has been described in case report …
Posttranslational modifications of keratins and their associated proteins as therapeutic targets in keratin diseases.
Li P, Rietscher K, Jopp H, Magin TM, Omary MB. Li P, et al. Curr Opin Cell Biol. 2023 Dec;85:102264. doi: 10.1016/j.ceb.2023.102264. Epub 2023 Nov 3. Curr Opin Cell Biol. 2023. PMID: 37925932 Review.
Keratin gene mutations cause multiple rare monoallelic epithelial diseases termed keratinopathies, including the skin diseases Epidermolysis Bullosa Simplex (EBS) and Pachyonychia Congenita (PC), with limited available therapies. The disease-related keratin mutation …
Keratin gene mutations cause multiple rare monoallelic epithelial diseases termed keratinopathies, including the skin diseases Epidermolysis …
Pachyonychia congenita and botulinum toxin.
Thomas BR, Sahota A. Thomas BR, et al. Br J Dermatol. 2020 Mar;182(3):531-532. doi: 10.1111/bjd.18784. Epub 2019 Dec 25. Br J Dermatol. 2020. PMID: 31875943 No abstract available.
EGFR Signaling Is Overactive in Pachyonychia Congenita: Effective Treatment with Oral Erlotinib.
Basset J, Marchal L, Hovnanian A. Basset J, et al. J Invest Dermatol. 2023 Feb;143(2):294-304.e8. doi: 10.1016/j.jid.2022.08.045. Epub 2022 Sep 16. J Invest Dermatol. 2023. PMID: 36116508 Free article.
Pachyonychia congenita (PC) is a rare keratinizing disorder characterized by painful palmoplantar keratoderma for which there is no standard current treatment. ...
Pachyonychia congenita (PC) is a rare keratinizing disorder characterized by painful palmoplantar keratoderma for which there …
Phenotype and genotype features of Vietnamese children with pachyonychia congenita.
Chu HT, Dinh Duong TA, Le DH, Le TV, Nguyen BB, Dang CV, Vu QV. Chu HT, et al. Pediatr Neonatol. 2023 Jul;64(4):405-410. doi: 10.1016/j.pedneo.2022.09.018. Epub 2023 Jan 3. Pediatr Neonatol. 2023. PMID: 36658016 Free article.
BACKGROUND: Pachyonychia congenita (PC) is a group of autosomal dominant disorders caused by mutations in one of five keratin genes (KRT6A, KRT6B, KRT6C, KRT16, or KRT17). ...
BACKGROUND: Pachyonychia congenita (PC) is a group of autosomal dominant disorders caused by mutations in one of five keratin …
Symptomatic mucosal involvement in pachyonychia congenita: challenges in infants and young children.
Goldberg I, Mashiah J, Kutz A, Derowe A, Warshauer E, Schwartz ME, Smith F, Sprecher E, Hansen CD. Goldberg I, et al. Br J Dermatol. 2020 Mar;182(3):708-713. doi: 10.1111/bjd.18742. Epub 2019 Dec 25. Br J Dermatol. 2020. PMID: 31777952
BACKGROUND: Pachyonychia congenita (PC) is a rare autosomal dominant genodermatosis caused by a mutation in any one of five keratin genes (KRT6A, KRT6B, KRT6C, KRT16 or KRT17). ...Usually simple feeding solutions may prevent complications and failure to thrive. What …
BACKGROUND: Pachyonychia congenita (PC) is a rare autosomal dominant genodermatosis caused by a mutation in any one of five ke …
49 results